Hereditary Cancer Panel - Synlab

Hereditary Cancer Panel

Genetic predisposition to hereditary cancer

Why undergoing this examination?

About 5-10% of all cancers have a hereditary nature, indicating that there is some variation in germline cells that can be transmitted within a family lineage. Detecting variants in genes involved in hereditary cancer development indicates a higher risk of developing certain types of cancer throughout life. 

What is the exam?

The Extended Cancer Panel test involves the analysis of 105 genes, providing the identification of point mutations, small insertions, and deletions related to hereditary cancer. Identifying a genetic susceptibility to cancer allows the physician to establish specific effective measures, not only in early detection but also in prevention. 

For whom is it indicated?

  • Patients diagnosed with cancer at an early age (<50 years); 
  • Patients with a family history suggesting hereditary cancer or with family members affected by cancer at an early age; 
  • Patients affected by various types of tumors; 
  • Patients with cancer who want to know its possible hereditary nature; 
  • Any patient who wants to know their genetic predisposition for hereditary cancer. 


Next Generation Sequencing (NGS) 

Hereditary Cancer Panel

Genetic predisposition to hereditary cancer




Guaranteed by the experience of the absolute European leader in laboratory diagnostics. 


  • Identified alterations researched in the most complete and up-to-date databases; 
  • Any pathogenic or uncertain significance variant is confirmed through a new DNA extraction and Sanger sequencing. 


Extra Information 


DOCUMENTATION – Available on the SYNLAB for clients 
  • Informed Consent; 
  • Clinical Questionnaire; 
  • Family Medical History; 
  • Medical Request. 


  • Fasting is not necessary for the test.


Additional Information 


Delivery Time 

42 business days 

Sample Type 

10mL of total blood in EDTA 

Other exams oncology:

We want to share our news with you!

Stay informed by subscribing to our Newsletter and receive exclusive updates on cutting-edge diagnostic medicine worldwide.

Thank you for signing up to our Newsletter!

This email is already registered!

An error occurred, please try later!

Contact us